Ap2B1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Ap2B1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| AP-2 Complex Subunit Beta 1 | |
|---|---|
| Gene Symbol | AP2B1 |
| Full Name | Adaptor Related Protein Complex 2 Subunit Beta 1 |
| Chromosome | 17q12 |
| NCBI Gene ID | 163 |
| OMIM | 601027 |
| Ensembl ID | ENSG00000091640 |
| UniProt ID | P63010 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Neurodevelopmental Disorders |
AP2B1 encodes the beta-2 subunit of the AP-2 complex, essential for clathrin-mediated endocytosis. The beta-2 subunit contains a clathrin-binding box that connects AP-2 to clathrin lattices. AP-2 recognizes cargo via tyrosine-based motifs and di-leucine motifs in transmembrane proteins. In neurons, AP-2B1 regulates internalization of neurotransmitter receptors, ion channels, and synaptic proteins, playing critical roles in synaptic plasticity and homeostasis.
Ubiquitously expressed with high expression in brain. Enriched at synaptic membranes and endocytic zones.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Promoter variants | Risk factor | Impaired receptor internalization |
| Parkinson's Disease | R370W | Risk factor | Synaptic dysfunction |
| Neurodevelopmental | Missense | De novo | Synaptic development defects |
Ap2B1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Ap2B1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.